We have over 12,000 students, from over 100 countries, within one of the safest campuses in the UK


97% of Lancaster students go into work or further study within six months of graduating

Home > Research > Publications & Outputs > Banking expectations
View graph of relations

« Back

Banking expectations: the promises and problems of biobanks

Research output: Contribution to journalJournal article


<mark>Journal publication date</mark>11/2007
<mark>Journal</mark>Personalized Medicine
Number of pages7
<mark>Original language</mark>English


In the last decade, governments, medical charities, pharmaceutical companies and disease advocacy organizations have spent considerable time and money developing biobanks to aid drug discovery and the investigation of disease. This article identifies and assesses the various expectations that have driven the investment in different types of biobanks. It suggests that they have been the focus of unrealistic promises about producing a 'biobank revolution' that will transform biomedicine and healthcare. We need more modest expectations about what can be achieved, and need to tackle certain conceptual and methodological challenges for biobanks to fulfill their potential.